ComapanyName#Website#Founded#Headquarters#Industry#Type#Key people#Products#Number of employees#Revenue#Net income#Area served#Traded as#Founder#Operating income#Total assets#Total equity#Subsidiaries#Parent#Born#Owner#Occupation#Fate#Founders#Defunct#Died#Services#Known for#Predecessor#Number of locations#Formerly#Divisions#Successor#Former type#Spouse(s)#Nationality#Children#Native name#Country#Alma mater#ISIN#Production output
Genentech#www.gene.com#1976; 43 years ago (1976)#South San Francisco, California, United States#Biotechnology#Wholly owned subsidiary of Roche#Alexander Hardy, CEOEd HarringtonSandra J. Horning, M.D.Michael D. Varney, Ph.D.Sean JohnstonKimball HallNancy VitaleSeverin Schwan, Chairman of Genentech Board of Directors, CEO of Roche Group#Avastin, Herceptin, Rituxan, Perjeta, Kadcyla, Gazyva, Tarceva, Ocrevus, Tecentriq, Xofluza, Hemlibra, Venclexta, Esbriet, Cotellic, Alecensa, Zelboraf, Nutropin, Actemra, Lucentis, Xolair, Activase, Cathflo Activase, Xeloda, Boniva, TNKase, CellCept, Pegasys, Pulmozyme, Tamiflu, Valcyte, Anaprox, Cytovene, EC-Naprosyn, Erivedge, Fuzeon, Invirase, Klonopin, Kytril, Naprosyn, Rocephin, Roferon-A, Romazicon, Valium, Xenical, Zenapax#13,697 (February 2019)############Hoffmann-La Roche#####################